Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NZYM-B.CO Stock Summary
Top 10 Correlated ETFs
NZYM-B.CO
In the News
NZYM-B.CO Financial details
Company Rating
Strong Buy
Market Cap
184.54B
Income
3.02B
Revenue
17.9B
Book val./share
-
Cash/share
-
Dividend
10.2
Dividend %
2.79%
Employees
6.4K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
31.58
Forward P/E
26.78
PEG
-8.65
P/S
5.69
P/B
7
P/C
-
P/FCF
80.31
Quick Ratio
0.19
Current Ratio
1.52
Debt / Equity
0.03
LT Debt / Equity
0.02
-
-
EPS (TTM)
8.4
EPS next Y
14.84
EPS next Q
-
EPS this Y
-17.46%
EPS next Y
76.68%
EPS next 5Y
76.68%
EPS last 5Y
-0.25%
Revenue last 5Y
4.48%
Revenue Q/Q
3.3%
EPS Q/Q
-
-
-
-
-
SMA20
5.43%
SMA50
13.33%
SMA100
26.71%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
24%
ROC
0.2%
Gross Margin
54%
Oper. Margin
26%
Profit Margin
18%
Payout
52%
Shs Outstand
464.36M
Shs Float
352.81M
-
-
-
-
Target Price
-
52W Range
274.6-400.3
52W High
-0.65%
52W Low
+45.04%
RSI
50
Rel Volume
1.04
Avg Volume
623.05K
Volume
646.12K
Perf Week
-2.33%
Perf Month
7.58%
Perf Quarter
36.85%
Perf Half Y
37.56%
-
-
-
-
Beta
0.475
-
-
Volatility
6.41%, 12.99%
Prev Close
-2.62%
Price
397.4
Change
-2.29%
NZYM-B.CO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 50.16 | 49.68 | 53.35 | 62.64 | 64.41 | |
Net income per share | 11.01 | 10.02 | 11.23 | 13.12 | 10.88 | |
Operating cash flow per share | 11.15 | 15.44 | 14.5 | 14.3 | 14.94 | |
Free cash flow per share | 7.67 | 12.11 | 10.07 | 3.98 | 7.54 | |
Cash per share | 2.53 | 4.61 | 3.7 | 4 | 4.16 | |
Book value per share | 40.02 | 39.83 | 42.2 | 49.38 | 50.3 | |
Tangible book value per share | 33.34 | 30.81 | 25.63 | 34.01 | 35.34 | |
Share holders equity per share | 40.02 | 39.83 | 42.2 | 49.38 | 50.3 | |
Interest debt per share | 16.71 | 13.61 | 2.08 | 1.83 | 1.95 | |
Market cap | 93.42B | 98.57B | 150.54B | 98.61B | 103.12B | |
Enterprise value | 97.41B | 101.16B | 150.06B | 97.98B | 102.37B | |
P/E ratio | 29.62 | 34.89 | 47.85 | 26.83 | 34.1 | |
Price to sales ratio | 6.5 | 7.03 | 10.07 | 5.62 | 5.76 | |
POCF ratio | 29.23 | 22.63 | 37.06 | 24.62 | 24.84 | |
PFCF ratio | 42.48 | 28.86 | 53.34 | 88.36 | 49.2 | |
P/B Ratio | 8.15 | 8.77 | 12.73 | 7.13 | 7.38 | |
PTB ratio | 8.15 | 8.77 | 12.73 | 7.13 | 7.38 | |
EV to sales | 6.78 | 7.22 | 10.04 | 5.58 | 5.72 | |
Enterprise value over EBITDA | 20.64 | 21.08 | 28.87 | 16.13 | 17.52 | |
EV to operating cash flow | 30.48 | 23.23 | 36.94 | 24.46 | 24.66 | |
EV to free cash flow | 44.3 | 29.62 | 53.17 | 87.8 | 48.84 | |
Earnings yield | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | |
Free cash flow yield | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 | |
Debt to equity | 0.41 | 0.34 | 0.04 | 0.03 | 0.03 | |
Debt to assets | 0.23 | 0.18 | 0.02 | 0.01 | 0.01 | |
Net debt to EBITDA | 0.85 | 0.54 | -0.09 | -0.1 | -0.13 | |
Current ratio | 1.49 | 1.66 | 1.38 | 1.33 | 1.3 | |
Interest coverage | 46.97 | 57.97 | 39.28 | 45.38 | 26.31 | |
Income quality | 1.01 | 1.54 | 1.29 | 1.09 | 1.37 | |
Dividend Yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | |
Payout ratio | 0.46 | 0.52 | 0.47 | 0.41 | 0.94 | |
Sales general and administrative to revenue | 0.06 | 0.05 | 0.06 | 0.05 | 0.05 | |
Research and developement to revenue | 0.14 | 0.14 | 0.13 | 0.11 | 0.11 | |
Intangibles to total assets | 0.09 | 0.12 | 0.2 | 0.17 | 0.16 | |
Capex to operating cash flow | -0.31 | -0.22 | -0.31 | -0.72 | -0.5 | |
Capex to revenue | -0.07 | -0.07 | -0.08 | -0.16 | -0.11 | |
Capex to depreciation | -0.84 | -0.74 | -0.88 | -1.98 | -1.48 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Graham number | 99.56 | 94.75 | 103.25 | 120.72 | 110.98 | |
ROIC | 0.2 | 0.19 | 0.25 | 0.26 | 0.24 | |
Return on tangible assets | 0.17 | 0.16 | 0.16 | 0.16 | 0.13 | |
Graham Net | -14.61 | -15.48 | -25.63 | -27.21 | -39.84 | |
Working capital | 2.32B | 2.75B | 2.15B | 2.28B | 2.2B | |
Tangible asset value | 9.55B | 8.69B | 7.18B | 9.53B | 9.82B | |
Net current asset value | -1.91B | -2.36B | -4.74B | -4.51B | -4.58B | |
Invested capital | 0.41 | 0.34 | 0.04 | 0.03 | 0.03 | |
Average receivables | 1.82B | 3.44B | 3.51B | 3.97B | 2.07B | |
Average payables | 1.27B | 1.11B | 1.3B | 1.68B | 1.74B | |
Average inventory | 2.72B | 2.49B | 2.68B | 3.4B | 3.72B | |
Days sales outstanding | 92.66 | 84.06 | 92.6 | 86.15 | 0 | |
Days payables outstanding | 63.51 | 65.19 | 85.94 | 85.53 | 72.13 | |
Days of inventory on hand | 148.56 | 139.92 | 172.58 | 174.03 | 161.9 | |
Receivables turnover | 3.94 | 4.34 | 3.94 | 4.24 | 0 | |
Payables turnover | 5.75 | 5.6 | 4.25 | 4.27 | 5.06 | |
Inventory turnover | 2.46 | 2.61 | 2.11 | 2.1 | 2.25 | |
ROE | 0.28 | 0.25 | 0.27 | 0.27 | 0.22 | |
Capex per share | -3.48 | -3.33 | -4.42 | -10.31 | -7.4 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.27 | 16.64 | 15.17 | 16.05 | 0 | |
Net income per share | 3.17 | 2.82 | 2.18 | 3.37 | 0 | |
Operating cash flow per share | 2.1 | 1.13 | 4.07 | 5.71 | 0 | |
Free cash flow per share | -1.14 | -0.41 | 2.09 | 4 | 0 | |
Cash per share | 4.03 | 4.26 | 4 | 4.29 | 0 | |
Book value per share | 49.7 | 46.36 | 48.17 | 52.16 | 0 | |
Tangible book value per share | 34.23 | 31.27 | 33.23 | 37.19 | 0 | |
Share holders equity per share | 49.7 | 46.36 | 48.17 | 52.16 | 0 | |
Interest debt per share | 0.11 | 1.88 | 1.55 | 1.35 | 0 | |
Market cap | 97.97B | 97.48B | 88.34B | 79.06B | 0 | |
Enterprise value | 97.34B | 96.79B | 87.69B | 78.26B | -747M | |
P/E ratio | 27.74 | 31.08 | 36.45 | 21.12 | 0 | |
Price to sales ratio | 21.63 | 21.09 | 20.95 | 17.74 | 0 | |
POCF ratio | 167.76 | 310.45 | 78.18 | 49.85 | 0 | |
PFCF ratio | -310.03 | -855.09 | 152.06 | 71.16 | 0 | |
P/B Ratio | 7.08 | 7.57 | 6.6 | 5.46 | 0 | |
PTB ratio | 7.08 | 7.57 | 6.6 | 5.46 | 0 | |
EV to sales | 21.49 | 20.94 | 20.79 | 17.56 | -0.16 | |
Enterprise value over EBITDA | 86.99 | 76.45 | 89.3 | 58.14 | -0.72 | |
EV to operating cash flow | 166.68 | 308.25 | 77.6 | 49.34 | -0.67 | |
EV to free cash flow | -308.03 | -849.05 | 150.93 | 70.44 | -1.44 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -0.56 | -0.54 | -0.67 | -0.6 | -0.72 | |
Current ratio | 1.33 | 1.35 | 1.37 | 1.52 | 1.3 | |
Interest coverage | -4.05 | 10.22 | 22.76 | 0 | 12.76 | |
Income quality | 0.67 | 0.39 | 1.84 | 1.71 | 1.61 | |
Dividend Yield | 0 | 0.02 | 0 | 0 | 0 | |
Payout ratio | 0 | 2.12 | 0 | 0 | 1.71 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0.12 | 0.11 | 0.12 | 0.1 | 0.11 | |
Intangibles to total assets | 0.17 | 0.16 | 0.16 | 0.16 | 0.16 | |
Capex to operating cash flow | -1.54 | -1.36 | -0.49 | -0.3 | -0.54 | |
Capex to revenue | -0.2 | -0.09 | -0.13 | -0.11 | -0.13 | |
Capex to depreciation | -2.43 | -1.2 | -1.64 | -1.43 | 0 | |
Stock based compensation to revenue | 0.02 | 0 | 0 | 0 | 0 | |
Graham number | 59.56 | 54.26 | 48.61 | 62.89 | 0 | |
ROIC | 0.09 | 0.06 | 0.05 | 0.05 | 0.08 | |
Return on tangible assets | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | |
Graham Net | -27.39 | -30.49 | -29.19 | -26.07 | 0 | |
Working capital | 2.28B | 2.48B | 2.54B | 3.22B | 2.2B | |
Tangible asset value | 9.53B | 8.69B | 9.24B | 10.33B | 9.82B | |
Net current asset value | -4.51B | -5.41B | -5.06B | -4.21B | -4.58B | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Average receivables | 4.11B | 4.35B | 4.43B | 4.34B | 2.19B | |
Average payables | 1.84B | 1.66B | 1.39B | 1.39B | 1.54B | |
Average inventory | 3.78B | 3.83B | 3.91B | 3.92B | 3.75B | |
Days sales outstanding | 82.33 | 88.7 | 91.79 | 88.3 | 0 | |
Days payables outstanding | 79.87 | 61.64 | 63.21 | 63.85 | 68.67 | |
Days of inventory on hand | 162.52 | 163.49 | 189.57 | 169.59 | 154.12 | |
Receivables turnover | 1.09 | 1.01 | 0.98 | 1.02 | 0 | |
Payables turnover | 1.13 | 1.46 | 1.42 | 1.41 | 1.31 | |
Inventory turnover | 0.55 | 0.55 | 0.47 | 0.53 | 0.58 | |
ROE | 0.06 | 0.06 | 0.05 | 0.06 | 0.05 | |
Capex per share | -3.23 | -1.54 | -1.98 | -1.71 | 0 |
NZYM-B.CO Frequently Asked Questions
What is Novozymes A/S stock symbol ?
Novozymes A/S is a DK stock and trading under the symbol NZYM-B.CO
What is Novozymes A/S stock quote today ?
Novozymes A/S stock price is $397.4 today.
Is Novozymes A/S stock public?
Yes, Novozymes A/S is a publicly traded company.